A review of current evidence for vilazodone in major depressive disorder
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of current evidence for vilazodone in major depressive disorder
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
Volume 17, Issue 3, Pages 160-169
Publisher
Informa UK Limited
Online
2013-04-12
DOI
10.3109/13651501.2013.794245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Adjunctive Therapy with Atypical Antipsychotics for Acute Treatment of Major Depressive Disorder
- (2012) Charu Taneja et al. ANNALS OF PHARMACOTHERAPY
- Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
- (2012) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder
- (2011) Arif Khan et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Association between Economic Status and Depressive Symptoms: An Individual and Community Level Approach
- (2011) Sun-Jin Jo et al. Psychiatry Investigation
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2009) J. Craig Nelson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study
- (2009) Pierre Blier et al. AMERICAN JOURNAL OF PSYCHIATRY
- Vilazodone: A 5-HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
- (2009) Lee A. Dawson et al. CNS Neuroscience & Therapeutics
- Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
- (2009) Arif Khan EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder
- (2009) Michael Bauer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination
- (2009) James H. Kocsis et al. JOURNAL OF CLINICAL PSYCHIATRY
- Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder
- (2009) Karl Rickels et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
- (2009) Ronald N. Marcus et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation
- (2009) B S McEwen et al. MOLECULAR PSYCHIATRY
- Low-Dose Buspirone, Melatonin and Low-Dose Bupropion Added to Mood Stabilizers for Severe Treatment-Resistant Bipolar Depression
- (2009) Andrew A. Nierenberg PSYCHOTHERAPY AND PSYCHOSOMATICS
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
- (2008) IM Anderson et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now